chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately a week after the second dose, we noticed white discoloration on knees, elbows, spine, ankles, wrists.  The discoloration spread over the next few weeks.  He was diagnosed with vitiligo and seen by his pediatrician, dermatologist, and integrative doctor.  Though no one is sure that the onset of the vitiligo was caused by the vaccine, all of the healthcare professionals said it could be possible.
Case number PHEH2013US005335 is an initial spontaneous report received from a medical assistant on 03 Mar 2013. This report refers to a patient whose identifiers were not reported. It was reported that the patient received intramuscularly only the MENVEO (batch number; not reported) without being reconstituted with MenA lyophilized conjugate. No adverse reactions were reported following the maladministration.
Let caller know that there is no information regarding a potential interaction between the vaccine and having someone's eyes dilated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 81 year-old female patient received bnt162b2 (BNT162B2), administration date 11May2021 (Batch/Lot number: unknown) at the age of 81 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "oral surgery", start date: 06May2021 (unspecified if ongoing); "will be undergoing arterial surgery", start date: 06May2021 (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose:1st), administration date: 20Apr2021, for Covid-19 immunization. The following information was reported: EYE DISORDER (non-serious), outcome "unknown", described as "Let caller know that there is no information regarding a potential interaction between the vaccine and having someone's eyes dilated".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021 at 10:38 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 10:33 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was reported as 61.75 on 27-Feb-2021 and 61.82 on 27-Mar-2021. Concomitant products were not provided. For Lot no : 014M20A, excursion time was 9 AM, 11AM, 12PM, 1PM, 2PM, 3PM, 4PM and 5PM and temperature was 33, 35, 35, 35, 35, 34, 34, and 35 respectively, total doses given for the day was 199, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 24-Feb-2021 was moved to clinic on 27-Feb-2021. 20 vial was sent to clinic. Vaccine BUD date was 26-Mar-2021. For Lot no : 019B21A, excursion time was 9 AM and 10 AM  and temperature was 35 and 35 respectively, total doses given for the day was 195, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 23-Mar-2021 was moved to clinic on 27-Mar-2021, 20 vial was sent to clinic, Vaccine BUD date was 22-Apr-2021. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F. Treatment medications were not reported.
Approximately 12 hours after vaccine I awoke with chills. Within the following hour, had body aches, 102 fever, joint pain, headache. Symptoms lasted around 36 hours, with the worst in the first 20 hours, then gradually subsiding.
Pt recvd 1st dose Recomb w/no noted problems; Pt recvd 2nd dose of Recomb approx 1 mo prior ot pregnancy; LMP 13SEP90; monitoring of pregnancy demonstrated high alpha fetoprotein of 7.78; Herpes simplex noted; pt delivered nl child;
Patient waited approximately 5 minutes after administration to get up to leave the office. He fainted before leaving. He hit his head on the wall. Skin was pasty and very pale. He was nauseated. Cold compresses. Patient lay down for about 15 minutes before blood pressure returned to normal.
Rash and itchy all over body. Seen at urgent care. Given steroid shot and prednisone 40 mg.
Patient complains of fatigue and dizziness NO DIB or allergic symptoms VS - 106/77 HR 74 98% O2 Physical exam unremarkable Given gatorade and felt back to baseline within 10 min Observed for total of 1 hour and discharged home with precautions to go to ER for any allergic symptoms
Headache, Arthralgia, Fever,  fatigue Employee states she had previously tested positive for COVID19 on 27Nov20
Pt recvd a series of 3 doses of Engerix-B on 10MAR91, 20APR91, & 29SEP91 & 8NOV91 serology indicated "non-responder" no tx was given;
Bell's palsy; This case was reported by a lawyer and described the occurrence of bell's palsy in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The initial information received on 31 March 2021 (case now medically confirmed).  The patient had Shingrix. On an unknown date patient had bell's palsy.
"swelling and redness around vaccine site, approx 3" above and below injection site."
Experienced difficulty breathing after playing basketball with my son. Went to Hospital and initially was told that I may have Pneumonia. Then an EKG revealed that I had an issue with my heart. An Ultrasound revealed that mu heart was operating at 30%. Catheterization did not reveal any blockage.
Mother reports 3 pox; 1 at forehead hairline mid-line; 1 at middle of back; and 1 at forearm. Filled with fluid, 2 days before scabbing. Received vaccine on 9/28/00 and broke out with chickenpox on 3/5/01. Vaccine did not prevent disease.
Breakthrough flare of psoriasis after receiving vaccines, was 100% clear and in remission.  Started 8/01/21
I was 10 days late on starting my period. I have not been even a day late for over 8 years. Typically, my cycle even runs a couple days early.
3 hours after receiving the second shot. I experienced chills, and extreme fatigue. The second and 3rd day, I experienced a piercing headache, fever, fatigue, weakness, and a rash across my chest and around my lips. My lips slightly swole u and itched. As of today, my lips are experiencing an allergic reaction. They itch and now are peeling. I?ve been taking Zyrtec, but it?s not helping. Tomorrow I plan on buying benedryl to help.
pt recvd vax;fever 103.5;apap given at bedtime;woke up screaming;fever 105;to er; p/ 2-3 hrs fever came down; changed ATB from amoxicillin to Keflex;MD felt DTP rxn was related to bronchitis (sxs of bronchitis gone);
mom states pt devel irritability & T102 for 1 noc which started 1hr p/vax;
Injection site pain; myalgia; abdominal pain; This is a spontaneous report from a contactable physician. A 40-year-old male patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number: unknown), via an unspecified route of administration on 21Dec2020 (19:15 PM) at single dose for COVID-19 immunization. There was no medical history. Concomitant medications were not reported. The patient has not been diagnosed with Covid-19 prior to vaccination. No know allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no other vaccine in four weeks and other medications in two weeks. The patient experienced injection site pain, myalgia, and abdominal pain on 22Dec2020 (09:00 AM). There was no treatment received for the adverse event. The patient was not tested for Covid-19 post vaccination. The outcome of events was recovering. This case is reported as non-serious.   Information on the lot/batch number has been requested.
itching at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039U20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itching at injection site). At the time of the report, VACCINATION SITE PRURITUS (itching at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Patient received the Moderna booster dose. Patient states they started feeling hot all over and experiencing tingling of the right hand. Patient denied difficulty breathing, chest pain, vision changes, or disorientation. No diaphoresis. Patient's vital signs resulted within normal range for adult females; temperature 98.4F. Patient given water & juice. Ice packs used to help with over heating sensation. Symptoms completely resolved within 30 minutes. Patient remained under observation of provider for over 30 minutes after symptoms presented. Patient remained alert and oriented x3.
This spontaneous report as received from a medical assistant refers to a 14-year-old patient of unknown gender. No information about the patient's medical history and concurrent conditions were reported. On 08-FEB-2016, the patient was vaccinated with an improperly stored, the third dose of GARDASIL lot # K008931, expiry date 04-MAR-2017, (dose and route of administration were not reported). Concomitant therapy was not reported. Administered doses were exposed to the following conditions: temperature of 33 Fahrenheit degrees for 15 hours and 15 minutes. There was no previous temperature excursion. It was not the case of a "data logger". No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected as all required correspondence was received.
Pt's mother called on 8/10/01 and said pt had developed a lump at Comvax or varicella injection site. On 8/11/01, pt developed raised lump at varicella injection site with "bumps". On 8/21/01, pt came in for office visit and has what appears to be chickenpox only at varicella injection site in less than a 1" circle. He denies fever or any other symptoms.
The day after the patient received the DTAP and Varicella vaccinations, the patient developed a red, raised area approximately 5 cm around/across and several other red whelped areas.
vaginal spotting; floaters in the right eye; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 69-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Oct2022 at 10:00 as dose 5 (booster), single (Lot number: GH9693) at the age of 69 years intramuscular, in right arm for covid-19 immunisation. The patient's relevant medical history included: "lupus" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Sulfur, reaction(s): "Known allergies: sulfur". Vaccination history included: Covid-19 vaccine (DOSE 4 (BOOSTER) SINGLE,, Unknown Manufacturer), for Covid-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE,, Unknown Manufacturer), for Covid-19 immunization; Covid-19 vaccine (DOSE 2, SINGLE,, Unknown Manufacturer), for Covid-19 immunization; Covid-19 vaccine (DOSE 1, SINGLE,, Unknown Manufacturer), for Covid-19 immunization. The following information was reported: VITREOUS FLOATERS (non-serious) with onset 11Nov2022 at 07:00, outcome "recovering", described as "floaters in the right eye"; POSTMENOPAUSAL HAEMORRHAGE (medically significant) with onset 11Nov2022 at 07:00, outcome "recovering", described as "vaginal spotting". The events "vaginal spotting" and "floaters in the right eye" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Aug2022) Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of postmenopausal haemorrhage, vitreous floaters. Clinical course: Patient had not received any other vaccine in four weeks. The patient received other medications in two weeks. Started having floaters in the right eye and vaginal spotting, treatment with Scrapped the uterus under local anesthesia. No covid prior vaccination, Post vaccination covid tested (Negative).
I received my second dose of the Pfizer vaccine on Nov. 3. On Nov. 12, I had a kale salad for dinner and thought it tasted strange, like rubber. At the time I thought it was just the taste of kale, because I'd never had raw kale before. But since then, I've noticed the same very weird burnt rubber taste and smell (both) whenever I have coffee, white wine, kale, turkey, and a few other foods ? those are just the ones I am most certain about because I drink coffee every day and have wine a few times a week. I have never tasted or smelled this particular taste/smell before and am concerned that it is parosmia from the vaccine. It has not gone away yet as of today 11-21-21. I have not yet sought any treatment. I am hoping my regular sense of taste and smell will return. I did not lose my taste or smell, and I can still taste and smell everything. It?s just that some foods now have that weird burnt rubber taste and smell, but they never used to.   I should also note that I was diagnosed with Covid 19 on Dec 30, 2020. I was sick for about two weeks and I did lose my taste and smell completely for about 10 days. Then my taste and smell came back. Also I did not experience any distortion of taste or smell. I did, however, feel very exhausted and I had acid reflux throat issues for the next two months. I did see an ENT, who agreed that my symptoms could be long Covid. Those throat issues finally cleared up at the end of May 2021.  Now I am really confused as to why I would experience parosmia (taste and smell distortion) about 9 days after my second dose of Pfizer, but never before when I actually had Covid.
Fever and seizures. Patient was admitted to hospital on 7/17/07 to Dr. with the diagnosis of Bacteremia and Seizure. Initial treatment was: Rocephin 125 mg IVPB Q12 hrs, Tylenol 80 mg Q4hrs x3 then prn for fever. 8/8/07-records received for DOS 7/18-7/21/07 DC DX: UTI, Sepsis. Admitted with high fever and seizure Temp in ER 103.4 (R).
Arm pain below injection site.  Headache and nausea. Headache relived with ibuprofen. Tylenol did not help.  Nausea went away with headache.
Within 24 hours of my second dose, my period started 8 days early. I did not experience any of my usual pre menstrual symptoms but I did have a full length heavy period.
Redness and swelling to the site (L) upper arm) progressively getting worse with increased swelling, redness and itching, only at the site. Seen in ER 4/13/19. D/C home.
Ache all over. I felt very very achy from my head to my toes. Never have had a reaction from any shot before. I am fine now, just sick for 2 days.
This spontaneous report was received from a licensed practical nurse regarding an 89 year old female patient with allergy to LORTAB and silk tape. No pertinent medical history was reported. On 01-JAN-2012 the patient was vaccinated with ZOSTAVAX (lot number reported as 1599AA, expiration date 13-JAN-2013) (dose and route not specified) to prevent shingles. No other suspect therapies were reported. Concomitant therapies included CITRICAL +D, PROCRIT, PRILOSEC, COUMADIN, VASOTEC, CELEXA, vitamins, LASIX, and PROSTAT. On 08-AUG-2013 the patient developed shingles after receiving ZOSTAVAX. The outcome for shingles was reported as not recovered. It was reported that the patient sought unspecified medical attention. The patient received VALTREX as treatment. No laboratory diagnostic studies were performed. The reporting nurse did not assess the causality between shingles and ZOSTAVAX. VZVIP packet was faxed. Additional information has been requested.
Lower leg swelling from below knee to top of foot at ankle. Very angry red and swollen. Causing fever shakes and fatigue. Taking Amoxik Clav 875-125 tab. Nort. Began talking on Tuesday for 3 days with slight improvement.
DIZZINESS; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included knees hurt.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 10-APR-2021, the subject experienced dizziness. On 10-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizziness, and nausea. This report was non-serious.
Fever of 101 degrees F.  Pain and swelling in the left arm.  Shaking/ Low blood sugar.
Case number PHEH2014US022362 is an initial spontaneous report received from a medical assistant on 05 Nov 2014. This report refers to a 26 years old female patient. Her medical history and concomitant medications were not reported. she was vaccinated with MENVEO (batch number: M14056) intramuscularly at a dose of 0.5 ml on 03 Nov 2014. It was reported that the vaccine administered reached 50 F for 30 minutes on 03 Nov 2014. No adverse events were reported following the medication error.
there was no adverse reaction to any dose.  Patient was given a third booster dose in error.  She is only 16 and does not qualify.  system will not let me enter this on subsequent page, but patient received the Afluria quadravalent flu vaccine, lot #P100352313 on 9/18/2021 (within one month prior to 3rd COVID dose)
Patient has become forgetful after Covid-19 infection.; high blood pressure which started in April of 2022 and may be related to her Covid-19 infection.; patient caught Covid-19 after her first Moderna Covid-19 booster dose.; This spontaneous case was reported by a patient and describes the occurrence of MEMORY IMPAIRMENT (Patient has become forgetful after Covid-19 infection.), HYPERTENSION (high blood pressure which started in April of 2022 and may be related to her Covid-19 infection.) and COVID-19 (patient caught Covid-19 after her first Moderna Covid-19 booster dose.) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001J212A and 053B22A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Hypertension and Hypercholesteremia. Concomitant products included METOPROLOL and PARACETAMOL (TYLENOL) for an unknown indication.   On 02-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2022, the patient experienced HYPERTENSION (high blood pressure which started in April of 2022 and may be related to her Covid-19 infection.) and COVID-19 (patient caught Covid-19 after her first Moderna Covid-19 booster dose.). On an unknown date, the patient experienced MEMORY IMPAIRMENT (Patient has become forgetful after Covid-19 infection.). At the time of the report, MEMORY IMPAIRMENT (Patient has become forgetful after Covid-19 infection.), HYPERTENSION (high blood pressure which started in April of 2022 and may be related to her Covid-19 infection.) and COVID-19 (patient caught Covid-19 after her first Moderna Covid-19 booster dose.) outcome was unknown.            Patient was using unspecified high Cholesterol medication as a concomitant product. Patient was experienced Fever, cough, muscular weakness and headache as a symptom of covid-19. All the events were experienced after the covid-19 infection.  No treatment information was provided by the reporter. The patient had headaches and high blood pressure which started in April of 2022 and may be related to her Covid-19 infection.   This case was linked to US-MODERNATX, INC.-MOD-2022-653180, US-MODERNATX, INC.-MOD-2022-653189 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-653180:Dose 1 US-MODERNATX, INC.-MOD-2022-653189:Dose 2
Started feeling sick with headache, fever of 101-102, neck pain. Heat in right arm with tenderness, redness. Doctor prescribed Tylenol and monitored. Doctor also prescribed Benadryl, Clariton.
adverse event: dizziness, dry heaving; treatment: rest, adequate hydration, bland diet
Telephone call from mother 5/23/13 reports significant local reaction to left arm at injection site of KINRIX (Dtap-UPV). Mom reports area oval shape approx 2" x 3", no fever; arm red, slightly tender, offered appt. Mom decided to wait, apply cold compresses, call with additional concerns.
Right upper arm swelling, pain, erythema, fever, sx began 24 hours. Treated with ibuprofen and antibiotics.
Received second dose of vaccine on 2/19.  presented to this  ED on 2/20/21 with generalized weakness.
Swelling of both legs right greater than left.  Seen in ER and given tylenol.
Information has been received from a medical assistant concerning a 16 year old female patient with not known medical history or drug reactions/allergies who on 01-JUL-2009 and 10-JAN-2009 was vaccinated with a first and second dose of GARDASIL respectively (expiration date on 13-JUN-2010 for both doses). There was no concomitant medication. The medical assistant reported that the patient experienced episodes of a sore throat after the first doses of GARDASIL. A blood test in February 2010 was positive for Epstein Barr Virus. No medications used to treat this but rest was required. Because of being ill, the third dose was delayed and was given in 06-MAY-2010. The patient sought unspecified medical attention. At the time of this report, the patient had recovered on an unspecified date. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to an 11 week old patient. On 24-MAR-2015, the patient was vaccinated with the first 0.5 ml dose of RECOMBIVAX HB (lot # not reported) intramuscularly. On 11-JUN-2015, the patient received the second 0.5 ml of RECOMBIVAX HB (lot # not reported) intramuscularly and on 30-JUL-2015, the patient received the third 0.5 ml dose of RECOMBIVAX HB (lot # K009953 exp date 03-APR-2016) intramuscularly. No adverse effect was reported. Additional information has been requested.